Form 8-K - Current report:
SEC Accession No. 0001206774-20-002736
Filing Date
2020-09-04
Accepted
2020-09-04 16:30:21
Documents
13
Period of Report
2020-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3801931-8k.htm   iXBRL 8-K 26883
2 AT MARKET ISSUANCE SALES AGREEMENT, DATED SEPTEMBER 4, 2020 geron3801931-ex101.htm EX-10.1 194612
  Complete submission text file 0001206774-20-002736.txt   447494

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20200904.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20200904_pre.xml EX-101.PRE 22704
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20200904_lab.xml EX-101.LAB 34591
6 EXTRACTED XBRL INSTANCE DOCUMENT geron3801931-8k_htm.xml XML 3610
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 201162125
SIC: 2834 Pharmaceutical Preparations